Saquon Barkley is taking equity, not cash, in his next endorsement round
The Eagles running back is structuring deals with startups around ownership stakes, testing a model other stars will watch.
Philadelphia Eagles running back Saquon Barkley is negotiating equity positions in at least three early-stage companies instead of accepting traditional endorsement fees, according to people familiar with the arrangements. The shift puts him in a small cohort of NFL players—fewer than twelve by recent count—who routinely trade immediate cash for ownership stakes in ventures they publicly support.
Barkley's team is targeting consumer brands with revenue between $5 million and $20 million, where his endorsement can materially move sales and where equity grants of 2% to 5% represent meaningful upside without diluting founders below comfort. One recent deal involved a direct-to-consumer nutrition company that offered him 3.5% in exchange for two years of social promotion and quarterly product feedback sessions. The cash equivalent would have been roughly $400,000 annually. Barkley took the equity.
This matters because it signals a structural change in how marquee athletes allocate their off-field capital. Traditional endorsement deals pay athletes to wear, mention, or appear. Equity deals pay athletes to build. The economic logic is simple: a $500,000 annual endorsement fee over three years nets $1.5 million. A 3% stake in a company that exits at $200 million nets $6 million. The risk is also simple: most startups fail, and equity in a shuttered venture is worth exactly zero.
Barkley's approach follows a template set by stars in other leagues. Kevin Durant's Thirty Five Ventures has stakes in over eighty companies, including Postmates, which returned roughly $15 million when it sold to Uber. Naomi Osaka took equity in Bodyarmor before Coca-Cola bought it for $5.6 billion, netting her a reported $10 million payout on a deal that started as a mid-six-figure cash arrangement. NFL players have been slower to adopt the model, partly because shorter careers and higher injury risk make immediate cash more appealing, and partly because the league's marketing apparatus has favored big checks from legacy brands.
The shift has second-order effects on how sponsors allocate budgets. A consumer brand with $2 million to spend on athlete marketing can either pay LeBron James $2 million in cash, or offer a rising star $500,000 in cash plus 4% equity, keeping $1.5 million for product development. The equity route gets the brand a longer-term partner with skin in the outcome, but it also means the athlete's incentives shift: they care about revenue growth, not just brand awareness. That changes the deliverables. Barkley's deals now include quarterly product input and access to his agent's network for fundraising introductions.
Family offices and private equity shops are watching this closely. If top athletes start taking equity at scale, it creates a new distribution channel for consumer startups and a new way to price early-stage risk. An athlete with 10 million Instagram followers who takes 3% equity is effectively underwriting the company's customer acquisition cost with their personal brand. That makes the company more attractive to institutional investors, who see the athlete as both a marketing engine and a validation signal. It also makes the athlete a quasi-operator, not just a spokesperson.
Barkley's team is being selective. They passed on at least four deals in the past six months where the company's valuation felt inflated or the founder's track record was thin. The filter is not just upside—it is reputation risk. An equity partner who promotes a failed product looks worse than a paid endorser who simply moves on. The calculus is different when your name is on the cap table.
What to watch: Barkley's agent, who also represents several other Pro Bowl-level players, is expected to pitch the equity model to at least three more clients before the 2025 season. One is a wide receiver with a shoe deal up for renewal. Another consumer brand Barkley recently joined is planning a Series A round in Q2 2025, and his involvement is expected to be highlighted in the deck. If that round closes at a meaningful step-up, expect more athletes to ask their reps about points instead of dollars.
The test case is not whether Barkley gets rich. It is whether other athletes see equity as worth the wait, and whether brands see athlete-owners as better partners than athlete-spokespeople. If both answer yes, the endorsement business starts to look more like venture capital, and the athletes who win are the ones who can pick companies, not just cash checks.